Tyrphostin A1

CAS No. 2826-26-8

Tyrphostin A1( Tyrphostin 1 | AG9 )

Catalog No. M20945 CAS No. 2826-26-8

Tyrphostin A1 is an inhibitor of EGFR tyrosine kinase .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 27 In Stock
10MG 42 In Stock
25MG 80 In Stock
50MG 113 In Stock
100MG 147 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tyrphostin A1
  • Note
    Research use only, not for human use.
  • Brief Description
    Tyrphostin A1 is an inhibitor of EGFR tyrosine kinase .
  • Description
    Tyrphostin A1 is an inhibitor of EGFR tyrosine kinase .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tyrphostin 1 | AG9
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2826-26-8
  • Formula Weight
    184.19
  • Molecular Formula
    C11H8N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (542.92 mM)
  • SMILES
    COc1ccc(C=C(C#N)C#N)cc1
  • Chemical Name
    2-[(4-Methoxyphenyl)methylidene]propanedinitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Du C Bright J J Sriram S . Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice[J]. Journal of Neuroimmunology 2001 114(1-2):69-79.
molnova catalog
related products
  • CGP77675

    CGP77675 is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and autophosphorylation of purified Src. CGP77675 exhibits anticancer activity.

  • Peiminine

    Peiminine is an effective inhibitor for lung inflammation and pulmonary fibrosis in a rat model of bleomycin-induced lung injury.

  • Alflutinib

    Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.